Astellas Pharma, Inc. (ALPMY)
15.95
+0.18
(+1.14%)
USD |
OTCM |
Oct 23, 16:00
Astellas Pharma Market Cap : 28.60B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 28.60B |
| October 22, 2026 | 28.28B |
| October 21, 2026 | 28.11B |
| October 20, 2026 | 27.76B |
| October 19, 2026 | 27.15B |
| October 16, 2026 | 27.13B |
| October 15, 2026 | 26.73B |
| October 14, 2026 | 25.73B |
| October 13, 2026 | 25.80B |
| October 12, 2026 | 25.73B |
| October 09, 2026 | 25.73B |
| October 08, 2026 | 25.46B |
| October 07, 2026 | 25.53B |
| October 06, 2026 | 25.37B |
| October 05, 2026 | 25.48B |
| October 02, 2026 | 25.68B |
| October 01, 2026 | 25.89B |
| September 30, 2026 | 25.94B |
| September 29, 2026 | 26.54B |
| September 28, 2026 | 26.81B |
| September 25, 2026 | 27.29B |
| September 24, 2026 | 26.68B |
| September 23, 2026 | 27.00B |
| September 22, 2026 | 27.52B |
| September 21, 2026 | 27.27B |
| Date | Value |
|---|---|
| September 18, 2026 | 27.22B |
| September 17, 2026 | 27.24B |
| September 16, 2026 | 26.48B |
| September 15, 2026 | 26.64B |
| September 14, 2026 | 26.63B |
| September 11, 2026 | 26.11B |
| September 10, 2026 | 25.50B |
| September 09, 2026 | 25.87B |
| September 08, 2026 | 26.34B |
| September 04, 2026 | 26.98B |
| September 03, 2026 | 27.74B |
| September 02, 2026 | 27.11B |
| September 01, 2026 | 26.72B |
| August 31, 2026 | 26.50B |
| August 28, 2026 | 26.41B |
| August 27, 2026 | 26.81B |
| August 26, 2026 | 26.93B |
| August 25, 2026 | 27.18B |
| August 24, 2026 | 26.97B |
| August 21, 2026 | 26.97B |
| August 20, 2026 | 26.82B |
| August 19, 2026 | 27.09B |
| August 18, 2026 | 25.86B |
| August 17, 2026 | 25.69B |
| August 14, 2026 | 26.39B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 63.97B |
| Daiichi Sankyo Co., Ltd. | 32.48B |
| Eisai Co., Ltd. | 9.186B |
| Chugai Pharmaceutical Co., Ltd. | 70.88B |
| Santen Pharmaceutical Co., Ltd. | 3.594B |
Market Cap Related Metrics
| PE Ratio | 12.16 |
| PS Ratio | 1.948 |
| PEG Ratio | 0.0382 |
| Price to Book Value | 2.393 |
| Price to Free Cash Flow | 9.269 |
| Price | 15.95 |
| Earnings Yield | 8.22% |
| PEGY Ratio | 0.0382 |
| Operating PE Ratio | 8.955 |
| Normalized PE Ratio | 12.17 |